Company intelligence / Profile preview

Diplomat Pharmacy

Flint, Michigan, USAspecialtypharmacycontinuum.com ↗

Ownership: Private
Employees: ~2400
Development stage: Commercial

Overview

Diplomat was the largest independent specialty pharmacy in the U.S., providing medication management and infusion services for patients with complex chronic diseases. It did not develop its own drugs but dispensed specialty medications nationwide. The company was acquired by OptumRx in December of 2019 for $300 million.

Therapeutic areas: OncologyPulmonologyEndocrinologyImmunologyHematologyDermatologyRheumatologyGastroenterologyNeurologyInfectious Diseases
Modalities: Small moleculeBiologicMonoclonal antibodyInfusion therapy
Industry: Non-Academic Healthcare

Partnerships

Partnered with manufacturers of specialty drugs and health systems across the U.S.

Beyond the preview

Go deeper on Diplomat Pharmacy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diplomat Pharmacy.

Explore the full profile